A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke

BACKGROUND: Ticagrelor is one of the most recent antiplatelet drugs to be approved to treat ischemic heart disease. Its efficacy may exceed aspirin in improving clinical outcomes in patients with acute ischemic stroke who are ineligible for rt-PA. OBJECTIVES: We evaluated the safety regarding hemorr...

Descripción completa

Detalles Bibliográficos
Autores principales: Aref, Hany M., El-Khawas, Hala, Elbassiouny, Ahmed, Shokri, Hossam M., Zeinhom, Mohamed G., Roushdy, Tamer M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Clinical Trial article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842543/
https://www.ncbi.nlm.nih.gov/pubmed/36446950
http://dx.doi.org/10.1007/s10072-022-06525-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842543/
https://www.ncbi.nlm.nih.gov/pubmed/36446950
http://dx.doi.org/10.1007/s10072-022-06525-7

Ejemplares similares